hit counter

Rexulti (Brexpiprazole) & Weight Gain: Will It Make You Fat?

Rexulti (Brexpiprazole), is an atypical antipsychotic that was jointly developed by pharmaceutical companies Otsuka and Lundbeck.  In 2015, the FDA approved Rexulti for the treatment of schizophrenia and major depressive disorder (as an adjunct).  Rexulti functions as a “serotonin-dopamine activity modulator” (SDAM) and is intended to be a superior successor to the antipsychotic Abilify (Aripiprazole) …

Read more

Latuda Unlikely To Cause Weight Gain; Considered “Weight Neutral”

Latuda (Lurasidone) is a relatively new atypical antipsychotic that was approved in 2013 for the treatment of schizophrenia and depressive episodes in Type 1 Bipolar disorder. Many have made the argument that since this is a “newer” antipsychotic, it’s likely to be “better” than the crop of older medications on the market. While no single …

Read more